1 and ET-3 Inhibit Estrogen and Camp Production by Rat Granulosa Cells in Vitro

Total Page:16

File Type:pdf, Size:1020Kb

1 and ET-3 Inhibit Estrogen and Camp Production by Rat Granulosa Cells in Vitro 209 Endothelin (ET)-1 and ET-3 inhibit estrogen and cAMP production by rat granulosa cells in vitro A E Calogero, N Burrello and A M Ossino Division of Andrology, Department of Internal Medicine, University of Catania, 95123 Catania, Italy (Requests for offprints should be addressed to A E Calogero at Istituto di Medicina Interna e Specialita` Internistiche, Ospedale Garibaldi, Piazza S.M. di Gesu`, 95123 Catania, Italy) Abstract Endothelin (ET)-1 and ET-3, two peptides with a potent and a maximally stimulatory (3 mIU/ml) concentration of vasoconstrictive property, produce a variety of biological FSH. ET-1 and ET-3 dose-dependently suppressed basal effects in different tissues by acting through two different and FSH (1 mIU/ml)-stimulated cAMP production. ET-3 receptors, the ET-1 selective ETA receptor and the non- and SFX-S6c were significantly more potent than ET-1 in selective ETB receptor. An increasing body of literature suppressing estrogen production, suggesting that this effect suggests that ET-1 acts as a paracrine/autocrine regulator was not mediated by the ETA receptor. Indeed, BQ-123, of ovarian function. Indeed, ETB receptors have been a selective ETA receptor antagonist, did not influence identified in rat granulosa cells and ET-1 is a potent the inhibitory effects of ET-1 and ET-3 on basal and inhibitor of progesterone production. In contrast, incon- FSH-stimulated estrogen release. To determine a possible sistent data have been reported about the role of ET-1 on involvement of prostanoids, we evaluated the effects of estrogen production and the effects of ET-3 are not maximally effective concentrations of ET-1 and ET-3 on known. Therefore, the present study was undertaken to estrogen and cAMP production in the presence of in- evaluate the effects of ET-1 and ET-3 on estrogen and domethacin, a prostanoid synthesis inhibitor. This com- cAMP production, and the receptor type involved. Given pound did not have any effect on the suppressive effects of that prostanoids modulate ovarian steroidogenesis and that ETs on basal or FSH (1 mIU/ml)-stimulated estrogen or many actions of ETs are mediated by these compounds, we cAMP production. also evaluated whether the effects of ETs on estrogen and In conclusion, ET-1 and ET-3 were able to inhibit cAMP production might be prostanoid-mediated. ET-1, estrogen and cAMP production by rat granulosa cells, ET-3, and safarotoxin-S6c (SFX-S6c), a selective ETB indicating that the inhibitory effects of ETs on ovarian receptor agonist, inhibited basal estrogen production by steroidogenesis are not limited to progesterone biosyn- granulosa cells obtained from immature, estrogen-primed thesis. This effect does not appear to be mediated by female rats, in a concentration-dependent manner. All prostanoids or by the classical ETA and ETB receptors, at three peptides were also capable of inhibiting the produc- least under these experimental conditions. tion of estrogen stimulated by a half-maximal (1 mIU/ml) Journal of Endocrinology (1998) 157, 209–215 Introduction blocked by the peptide antagonist, BQ-123. Conversely, the ETB receptor binds ET-1 and ET-3 with equal affinity Endothelins (ETs), a family of 21-amino acid peptides, are and it is selectively activated by safarotoxin-S6c (SFX-S6c) present in three different isoforms coded by separate genes, (Bax & Saxena 1994). endothelin (ET)-1, ET-2, and ET-3 respectively (Inoue A number of studies have shown that ETs participate in et al. 1989). They were first isolated from endothelial the regulation of the endocrine system (Hirai et al. 1991, cells by virtue of their potent vasoconstrictor properties Masaki 1993, Calogero et al. 1994) and recent evidence (Yanagisawa et al. 1988). However, it soon became suggests that ETs may act as paracrine/autocrine regulators apparent that these peptides produce a variety of biological of ovarian endocrine function. Indeed, it has been shown effects (Masaki 1993) mediated by two distinct G-protein- that ETs are able to inhibit basal and gonadotropin- coupled receptors named ETA and ETB (Watanabe et al. stimulated progesterone production, cAMP accumulation, 1989). Although these receptors show about 63% amino and morphological transformation of granulosa cells in acid homology, they bind ET isopeptides and analogs with culture (Iwai et al. 1991, Flores et al. 1992, Tedeschi et al. different affinities. ETA has a more elevated affinity for 1992, 1994, Kamada et al. 1993). Although the effects ET-1 than for ET-3 and ETA-mediated cellular effects are of ETs on progesterone production are well known, Journal of Endocrinology (1998) 157, 209–215 1998 Society for Endocrinology Printed in Great Britain 0022–0795/98/0157–0209 $08.00/0 Downloaded from Bioscientifica.com at 09/23/2021 01:08:29PM via free access 210 A E CALOGERO and others · Endothelins and estrogen production inconsistent data have been reported on the role of ET-1 Bethesda, MD, USA), 35 µg/ml methyl-isobutylxanthine in estrogen production by granulosa cells (Kamada et al. (MIX; Sigma), and 1·25 µg/ml insulin (Eli Lilly Co., 1992, Tedeschi et al. 1994), and the effects of ET-3 are not Indianapolis, IN, USA). DES and MIX were added to known. Hence, this study was undertaken to evaluate the enhance the sensitivity of granulosa cells to FSH ( Jia & role of ET-1 and ET-3 on estrogen and cAMP production Hsueh 1986). At the end of the culture period, medium by granulosa cells obtained from immature, estrogen- samples were frozen at"20 )C until assayed for estrogen. primed rats, and to identify the ET receptor which medi- ates this effect. In consideration of the fact that prostanoids exert inhibitory effects on ovarian steroidogenesis Estrogen radioimmunoassay (Behrman & Caldwell 1986) and that a number of ET-1 The concentration of estrogen in the incubation medium actions are prostanoid-mediated (Anderson et al. 1995, was measured directly, without extraction, by radio- Howarth et al. 1995), we also evaluated whether indo- immunoassay, as previously reported (Calogero et al. methacin, a prostanoid synthesis inhibitor, modulates the 1996). Aliquots (200 µl) of medium, diluted 1:40–1:100, effects of ET-1 or ET-3 on estrogen or cAMP production. or standard solutions were incubated with 100 µl anti- serum (final dilution 1:10 000), and 100 µl [3H]estradiol Materials and Methods (E2) (about 9000 c.p.m.) at 4 )C for 18–20 h. Ice-cold charcoal-dextran was then added to achieve separation of Rat granulosa cell culture bound from free labeled hormone. Tubes were centrifuged at 1500 g at 4 )C for 11 min, the supernatants were Rat granulosa cells were cultured as previously reported collected and counted in a â-counter after the addition of ( Jia & Hsueh 1986, Calogero et al. 1996). Briefly, intact scintillation fluid. The anti-estrogen serum (RD/94/84; female immature (25 days old) Sprague-Dawley rats Analytical Antibodies, Segrate, MI, Italy) bound (Charles River, Calco, CO, Italy) were implanted sub- 3 40·7&2·5% (n=11) of [ H]E2. Non-specific binding cutaneously with a 10 mm Silastic brand capsule (Dow was 3·1&0·4%. The intra- and interassay coefficients of Corning, Midland, MI, USA) filled with diethylstilbestrol variation were 3·6&0·3% and 13·8% respectively. (DES; Sigma Chemical Co., St Louis, MO, USA). Four days after implantation, rats were sacrificed by cervical dislocation, and ovaries were removed for granulosa cell cAMP measurement collection. Ovaries were decapsulated, follicles were punc- tured with 27-gauge hypodermic needles, and granulosa At the end of the incubation, the medium was collected cells were carefully expressed into McCoy’s 5a medium for estrogen measurements and 0·5 ml ice-cold ethanol (Life Technologies, Paisley, Strathclyde, UK) to make a (90%) was added to each well. The plate was placed single cell suspension that was used for control and at"20 )C for 30 min and subsequently at 4 )C for 60– experimental cultures. An aliquot was diluted with trypan 90 min. Thereafter, each sample was collected and centri- blue stain, and viable cells were counted with a hemo- fuged in a microfuge, the supernatant collected, dried, cytometer. Cells were plated into 16 mm, 24-multiwell and stored at"20 )C until the day of the RIA. cAMP was plates (Corning, Milan, Italy) at a density of 50 000 viable measured by RIA using a commercially available kit (Amersham International plc, Amersham, Bucks, UK). cells/well/0·5 ml at 37 )C in a humidified, 95% air-5% cAMP antiserum bound 59·8&2·8% (n=2) of 125I-cAMP CO2 water-jacketed incubator in the presence of graded concentrations of ET-1 (Peninsula Laboratories Inc., (about 7000 c.p.m./100 µl). The detection limit (ED90)of Belmont, CA, USA), ET-3 (Peninsula), SFX-S6c (Sigma), the assay was 19·6 fmol/tube (49·0 fmol/well). The intra- BQ-123 (Peninsula), and/or indomethacin (Sigma) for six and interassay coefficients of variation were 1·3&0·3% days. BQ-123 or indomethacin were added simultaneously and 5·7% respectively. with ETs. Time-course studies showed that maximal estrogen production in response to increasing concen- Data analysis trations of follicle-stimulating hormone (FSH) (NIDDK hFSH B-1, AFP-8792B) was achieved after six days of Results, reported as means&... throughout the study, incubation (Calogero et al. 1996). Each treatment was are expressed as percentage of basal estrogen production. applied in triplicate within each experiment and each Statistical evaluation was performed by analysis of variance experiment was replicated at least three times. Incubation (ANOVA) followed by Duncan’s multiple range test. The was carried out using McCoy’s 5a medium supplemented effects of ET-1, ET-3, or SFX-S6c on basal and FSH- with 2 mM -glutamine (Life Technologies), 200 U/ml stimulated estrogen dose–response curves were analyzed penicillin, 200 µg/ml streptomycin sulfate, 0·5 µg/ml applying the four parameter logistic equation; a computer fungizone (Life Technologies), 10"6 M androstenedione program, ‘Allfit’, was employed for the computation (Sigma), 10"7 M DES (Sigma), 37·5 ng/ml human (DeLean et al.
Recommended publications
  • Cooperation of Endothelin-1 Signaling with Melanosomes Plays a Role In
    © 2015. Published by The Company of Biologists Ltd | Biology Open (2015) 4, 1213-1221 doi:10.1242/bio.011973 RESEARCH ARTICLE Cooperation of endothelin-1 signaling with melanosomes plays a role in developing and/or maintaining human skin hyperpigmentation Daiki Murase1,2,*, Akira Hachiya1,*,‡, Mamiko Kikuchi-Onoe1, Rachel Fullenkamp2, Atsushi Ohuchi1, Takashi Kitahara1, Shigeru Moriwaki1, Tadashi Hase1 and Yoshinori Takema3 ABSTRACT both long-term sun-exposure and chronological aging. Such Skin hyperpigmentation is characterized by increased melanin hyperpigmentation is also thought to be related to the existence of synthesis and deposition that can cause significant psychosocial and uneven skin tones often observed on sun-exposed areas. Regardless of psychological distress. Although several cytokine-receptor signaling the significant psychosocial distress associated with age spots, little is cascades contribute to the formation of ultraviolet B-induced cutaneous known about the detailed mechanisms responsible for them, except for hyperpigmentation, their possible involvement in other types of skin ultraviolet B (UVB)-induced pigmentation, despite the fact that many hyperpigmentation has never been clearly addressed. Since our researchers have tried to identify the melanogenic stimulatory factor(s) continuous studies using skin specimens from more than 30 subjects involved. with ethnic skin diversity emphasized a consistent augmentation in the In the course of UVB-induced pigmentation, three major steps in expression of endothelin-1 (ET-1) and its receptor (Endothelin B the epidermis, melanocyte proliferation, activation of melanin receptor, ET-B) in hyperpigmented lesions, including senile lentigos synthesis and melanosome transfer to keratinocytes, have been (SLs), the precise function of ET-1 signaling was investigated in the reported to be responsible for the increased melanogenesis (Okazaki .
    [Show full text]
  • Nitric Oxide As a Second Messenger in Parathyroid Hormone-Related Protein Signaling
    433 Nitric oxide as a second messenger in parathyroid hormone-related protein signaling L Kalinowski, L W Dobrucki and T Malinski Department of Chemistry and Biochemistry, Ohio University, Athens, Ohio, USA (Requests for offprints should be addressed to T Malinski, Department of Chemistry and Biochemistry, Ohio University, Biochemistry Research Laboratories 136, Athens, Ohio 45701–2979, USA; Email: [email protected]) (L Kalinowski was on sabbatical leave from the Department of Clinical Biochemistry, Medical University of Gdansk and Laboratory of Cellular and Molecular Nephrology, Medical Research Center of the Polish Academy of Science, Poland) Abstract Parathyroid hormone (PTH)-related protein (PTHrP) is competitive PTH/PTHrP receptor antagonists, 10 µmol/l produced in smooth muscles and endothelial cells and [Leu11,-Trp12]-hPTHrP(7–34)amide and 10 µmol/l is believed to participate in the local regulation of vascu- [Nle8,18,Tyr34]-bPTH(3–34)amide, were equipotent in lar tone. No direct evidence for the activation of antagonizing hPTH(1–34)-stimulated NO release; endothelium-derived nitric oxide (NO) signaling pathway [Leu11,-Trp12]-hPTHrP(7–34)amide was more potent by PTHrP has been found despite attempts to identify it. than [Nle8,18,Tyr34]-bPTH(3–34)amide in inhibiting Based on direct in situ measurements, it is reported here for hPTHrP(1–34)-stimulated NO release. The PKC inhibi- the first time that the human PTH/PTHrP receptor tor, H-7 (50 µmol/l), did not change hPTH(1–34)- and analogs, hPTH(1–34) and hPTHrP(1–34), stimulate NO hPTHrP(1–34)-stimulated NO release, whereas the release from a single endothelial cell.
    [Show full text]
  • A Focus on the Kisspeptin Receptor, Kiss1r
    Western University Scholarship@Western Electronic Thesis and Dissertation Repository 12-1-2014 12:00 AM Pathway-Specific Signaling and its Impact on erF tility: A Focus on the Kisspeptin Receptor, Kiss1r Maryse R. Ahow The University of Western Ontario Supervisor Dr. Andy Babwah The University of Western Ontario Graduate Program in Physiology A thesis submitted in partial fulfillment of the equirr ements for the degree in Doctor of Philosophy © Maryse R. Ahow 2014 Follow this and additional works at: https://ir.lib.uwo.ca/etd Part of the Molecular and Cellular Neuroscience Commons Recommended Citation Ahow, Maryse R., "Pathway-Specific Signaling and its Impact on erF tility: A Focus on the Kisspeptin Receptor, Kiss1r" (2014). Electronic Thesis and Dissertation Repository. 2537. https://ir.lib.uwo.ca/etd/2537 This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of Scholarship@Western. For more information, please contact [email protected]. PATHWAY-SPECIFIC SIGNALING AND ITS IMPACT ON FERTILITY: A FOCUS ON THE KISSPEPTIN RECEPTOR, Kiss1r (Thesis format: Monograph) by Maryse R. Ahow Graduate Program in Physiology A thesis submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy The School of Graduate and Postdoctoral Studies The University of Western Ontario London, Ontario, Canada © Maryse R. Ahow, 2014 Abstract Hypothalamic gonadotropin-releasing hormone (GnRH) is the master regulator of the neuroendocrine reproductive (HPG) axis and its secretion is regulated by various afferent inputs to the GnRH neuron.
    [Show full text]
  • The Anti-Apoptotic Role of Neurotensin
    Cells 2013, 2, 124-135; doi:10.3390/cells2010124 OPEN ACCESS cells ISSN 2073-4409 www.mdpi.com/journal/cells Review The Anti-Apoptotic Role of Neurotensin Christelle Devader, Sophie Béraud-Dufour, Thierry Coppola and Jean Mazella * Institut de Pharmacologie Moléculaire et Cellulaire, CNRS UMR 7275, Université de Nice-Sophia Antipolis, 660 route des Lucioles, Valbonne 06560, France; E-Mails: [email protected] (C.D.); [email protected] (S.B.-D.); [email protected] (T.C.) * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +33-4-93-95-77-61; Fax: +33-4-93-95-77-08. Received: 24 January 2013; in revised form: 15 February 2013 / Accepted: 26 February 2013 / Published: 4 March 2013 Abstract: The neuropeptide, neurotensin, exerts numerous biological functions, including an efficient anti-apoptotic role, both in the central nervous system and in the periphery. This review summarizes studies that clearly evidenced the protective effect of neurotensin through its three known receptors. The pivotal involvement of the neurotensin receptor-3, also called sortilin, in the molecular mechanisms of the anti-apoptotic action of neurotensin has been analyzed in neuronal cell death, in cancer cell growth and in pancreatic beta cell protection. The relationships between the anti-apoptotic role of neurotensin and important physiological and pathological contexts are discussed in this review. Keywords: neurotensin; receptor; apoptosis; sortilin 1. Introduction The tridecapeptide neurotensin (NT) was isolated from bovine hypothalami on the basis of its ability to induce vasodilatation [1]. NT is synthesized from a precursor protein following excision by prohormone convertases [2].
    [Show full text]
  • Current Knowledge on the Multifactorial Regulation of Corpora Lutea Lifespan: the Rabbit Model
    animals Review Current Knowledge on the Multifactorial Regulation of Corpora Lutea Lifespan: The Rabbit Model Massimo Zerani , Angela Polisca *, Cristiano Boiti and Margherita Maranesi Dipartimento di Medicina veterinaria, Università di Perugia, via San Costanzo 4, 06126 Perugia, Italy; [email protected] (M.Z.); [email protected] (C.B.); [email protected] (M.M.) * Correspondence: [email protected] Simple Summary: Corpora lutea (CL) are temporary endocrine structures that secrete progesterone, which is essential for maintaining a healthy pregnancy. A variety of regulatory factors come into play in modulating the functional lifespan of CL, with luteotropic and luteolytic effects. Many aspects of luteal phase physiology have been clarified, yet many others have not yet been determined, including the molecular and/or cellular mechanisms that maintain the CL from the beginning of luteolysis during early CL development. This paper summarizes our current knowledge of the endocrine and cellular mechanisms involved in multifactorial CL lifespan regulation, using the pseudopregnant rabbit model. Abstract: Our research group studied the biological regulatory mechanisms of the corpora lutea (CL), paying particular attention to the pseudopregnant rabbit model, which has the advantage that the relative luteal age following ovulation is induced by the gonadotrophin-releasing hormone (GnRH). CL are temporary endocrine structures that secrete progesterone, which is essential for maintaining a healthy pregnancy. It is now clear that, besides the classical regulatory mechanism exerted by Citation: Zerani, M.; Polisca, A.; prostaglandin E2 (luteotropic) and prostaglandin F2α (luteolytic), a considerable number of other Boiti, C.; Maranesi, M. Current effectors assist in the regulation of CL. The aim of this paper is to summarize our current knowledge Knowledge on the Multifactorial of the multifactorial mechanisms regulating CL lifespan in rabbits.
    [Show full text]
  • View the Journal Article About Endogenous Opioids
    Journal of Pain Research Dovepress open access to scientific and medical research Open Access Full Text Article ORIGINAL RESEARCH Activation of endogenous opioid gene expression in human keratinocytes and fibroblasts by pulsed radiofrequency energy fields John Moffett1 Background: Pulsed radiofrequency energy (PRFE) fields are being used increasingly for Linley M Fray1 the treatment of pain arising from dermal trauma. However, despite their increased use, little Nicole J Kubat2 is known about the biological and molecular mechanism(s) responsible for PRFE-mediated analgesia. In general, current therapeutics used for analgesia target either endogenous factors 1Life Science Department, 2Independent Consultant, involved in inflammation, or act on endogenous opioid pathways. Regenesis Biomedical Inc, Methods and Results: Using cultured human dermal fibroblasts (HDF) and human epider- Scottsdale, AZ, USA mal keratinocytes (HEK), we investigated the effect of PRFE treatment on factors, which are involved in modulating peripheral analgesia in vivo. We found that PRFE treatment did not inhibit cyclooxygenase enzyme activity, but instead had a positive effect on levels of endog- enous opioid precursor mRNA (proenkephalin, pro-opiomelanocortin, prodynorphin) and corresponding opioid peptide. In HEK cells, increases in opioid mRNA were dependent, at least in part, on endothelin-1. In HDF cells, additional pathways also appear to be involved. PRFE treatment was also followed by changes in endogenous expression of several cytokines, including increased
    [Show full text]
  • Capturing Peptide–GPCR Interactions and Their Dynamics
    molecules Review Capturing Peptide–GPCR Interactions and Their Dynamics Anette Kaiser * and Irene Coin Faculty of Life Sciences, Institute of Biochemistry, Leipzig University, Brüderstr. 34, D-04103 Leipzig, Germany; [email protected] * Correspondence: [email protected] Academic Editor: Paolo Ruzza Received: 31 August 2020; Accepted: 9 October 2020; Published: 15 October 2020 Abstract: Many biological functions of peptides are mediated through G protein-coupled receptors (GPCRs). Upon ligand binding, GPCRs undergo conformational changes that facilitate the binding and activation of multiple effectors. GPCRs regulate nearly all physiological processes and are a favorite pharmacological target. In particular, drugs are sought after that elicit the recruitment of selected effectors only (biased ligands). Understanding how ligands bind to GPCRs and which conformational changes they induce is a fundamental step toward the development of more efficient and specific drugs. Moreover, it is emerging that the dynamic of the ligand–receptor interaction contributes to the specificity of both ligand recognition and effector recruitment, an aspect that is missing in structural snapshots from crystallography. We describe here biochemical and biophysical techniques to address ligand–receptor interactions in their structural and dynamic aspects, which include mutagenesis, crosslinking, spectroscopic techniques, and mass-spectrometry profiling. With a main focus on peptide receptors, we present methods to unveil the ligand–receptor contact interface and methods that address conformational changes both in the ligand and the GPCR. The presented studies highlight a wide structural heterogeneity among peptide receptors, reveal distinct structural changes occurring during ligand binding and a surprisingly high dynamics of the ligand–GPCR complexes. Keywords: GPCR activation; peptide–GPCR interactions; structural dynamics of GPCRs; peptide ligands; crosslinking; NMR; EPR 1.
    [Show full text]
  • Dual Endothelin Receptor Blockade Acutely Improves Insulin Sensitivity in Obese Patients with Insulin Resistance and Coronary Artery Disease
    Emerging Treatments and Technologies ORIGINAL ARTICLE Dual Endothelin Receptor Blockade Acutely Improves Insulin Sensitivity in Obese Patients With Insulin Resistance and Coronary Artery Disease 1 2 GUNVOR AHLBORG, MD, PHD ADRIAN GONON, MD, PHD The vascular responses to ET-1 are 2 2 ALEXEY SHEMYAKIN, MD JOHN PERNOW, MD, PHD mediated via two receptor subtypes: ET 2 A FELIX B¨OHM, MD, PHD and ETB receptors (10,11). Both types of receptors are located on vascular smooth muscle cells and mediate vasoconstric- OBJECTIVE — Endothelin (ET)-1 is a vasoconstrictor and proinflammatory peptide that may tion. The ETB receptor is also located on inhibit glucose uptake. The objective of the study was to investigate if ET (selective ETA and dual endothelial cells and mediates vasodilata- ϩ ETA ETB) receptor blockade improves insulin sensitivity in patients with insulin resistance and tion by stimulating release of NO and coronary artery disease. prostacyclin. Early reports show that Ϯ ET-1 interferes with glucose metabolism RESEARCH DESIGN AND METHODS — Seven patients (aged 58 2 years) with as indicated by a drop in splanchnic glu- insulin resistance and coronary artery disease completed three hyperinsulinemic-euglycemic clamp protocols: a control clamp (saline infusion), during ET receptor blockade (BQ123), and cose production and peripheral glucose A utilization during ET-1 infusion in during combined ETA (BQ123) and ETB receptor blockade (BQ788). Splanchnic blood flow (SBF) and renal blood flow (RBF) were determined by infusions of cardiogreen and p- healthy subjects (12). Ferri et al. (4) dem- aminohippurate. onstrated a negative correlation between total glucose uptake and circulating ET-1 RESULTS — Total-body glucose uptake (M) differed between the clamp protocols with the levels in non–insulin-dependent diabe- highest value in the BQ123ϩBQ788 clamp (P Ͻ 0.05).
    [Show full text]
  • New Drugs and Emerging Therapeutic Targets in the Endothelin Signaling Pathway and Prospects for Personalized Precision Medicine
    Physiol. Res. 67 (Suppl. 1): S37-S54, 2018 https://doi.org/10.33549/physiolres.933872 REVIEW New Drugs and Emerging Therapeutic Targets in the Endothelin Signaling Pathway and Prospects for Personalized Precision Medicine A. P. DAVENPORT1, R. E. KUC1, C. SOUTHAN2, J. J. MAGUIRE1 1Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom, 2Deanery of Biomedical Sciences, University of Edinburgh, Edinburgh, United Kingdom Received January 26, 2018 Accepted March 29, 2018 Summary Key words During the last thirty years since the discovery of endothelin-1, Allosteric modulators • Biased signaling • G-protein coupled the therapeutic strategy that has evolved in the clinic, mainly in receptors • Endothelin-1 • Monoclonal antibodies • Pepducins • the treatment of pulmonary arterial hypertension, is to block the Single nucleotide polymorphisms action of the peptide either at the ETA subtype or both receptors using orally active small molecule antagonists. Recently, there Corresponding author has been a rapid expansion in research targeting ET receptors A. P. Davenport, Experimental Medicine and Immunotherapeutics, using chemical entities other than small molecules, particularly University of Cambridge, Addenbrooke's Hospital, Cambridge, monoclonal antibody antagonists and selective peptide agonists CB2 0QQ, United Kingdom. Fax: 01223 762576. E-mail: and antagonists. While usually sacrificing oral bio-availability, [email protected] these compounds have other therapeutic advantages with the potential to considerably expand drug targets in the endothelin Introduction pathway and extend treatment to other pathophysiological conditions. Where the small molecule approach has been During the last thirty years since the discovery retained, a novel strategy to combine two vasoconstrictor of endothelin-1 (ET-1), the therapeutic strategy that has targets, the angiotensin AT1 receptor as well as the ETA receptor evolved in the clinic, mainly in the treatment of in the dual antagonist sparsentan has been developed.
    [Show full text]
  • Paracrine Regulation of the Resumption of Oocyte Meiosis by Endothelin-1
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Developmental Biology 327 (2009) 62–70 Contents lists available at ScienceDirect Developmental Biology journal homepage: www.elsevier.com/developmentalbiology Paracrine regulation of the resumption of oocyte meiosis by endothelin-1 Kazuhiro Kawamura a,c,⁎, Yinghui Ye a,d, Cheng Guang Liang c, Nanami Kawamura a,b, Maarten Sollewijn Gelpke e, Rami Rauch c, Toshinobu Tanaka a, Aaron J.W. Hsueh c a Department of Obstetrics and Gynecology, Akita University School of Medicine, Akita 010-8543, Japan b Dermatology and Plastic Surgery, Akita University School of Medicine, Akita 010-8543, Japan c Divison of Reproductive Biology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA 94305-5317, USA d Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University School of Medicine, Zhejiang 310-006, China e Molecular Design and Informatics, Schering-Plough Corporation, Oss, P.O. Box 20, 5340 BH, The Netherlands article info abstract Article history: Mammalian oocytes remain dormant in the diplotene stage of prophase I until the resumption of meiosis Received for publication 13 August 2008 characterized by germinal vesicle breakdown (GVBD) following the preovulatory gonadotropin stimulation. Revised 5 November 2008 Based on genome-wide analysis of peri-ovulatory DNA microarray to identify paracrine hormone-receptor Accepted 24 November 2008 pairs, we found increases in ovarian transcripts for endothelin-1 and endothelin receptor type A (EDNRA) in Available online 7 December 2008 response to the preovulatory luteinizing hormone (LH)/human chorionic gonadotropin (hCG) stimulation. Keywords: Immunohistochemical analyses demonstrated localization of EDNRA in granulosa and cumulus cells.
    [Show full text]
  • Role of Endothelin Axis in Pancreatic Tumor Microenvironment
    University of Nebraska Medical Center DigitalCommons@UNMC Theses & Dissertations Graduate Studies Spring 5-6-2017 Role of Endothelin Axis in Pancreatic Tumor Microenvironment Suprit Gupta University of Nebraska Medical Center Follow this and additional works at: https://digitalcommons.unmc.edu/etd Part of the Cancer Biology Commons Recommended Citation Gupta, Suprit, "Role of Endothelin Axis in Pancreatic Tumor Microenvironment" (2017). Theses & Dissertations. 203. https://digitalcommons.unmc.edu/etd/203 This Dissertation is brought to you for free and open access by the Graduate Studies at DigitalCommons@UNMC. It has been accepted for inclusion in Theses & Dissertations by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. i Role of Endothelin Axis in Pancreatic Tumor Microenvironment By Suprit Gupta Presented to the Faculty of The Graduate College in the University of Nebraska In Partial fulfillment of Requirements For the degree of Doctor of Philosophy Department of Biochemistry and Molecular Biology Under the Supervision of Dr. Maneesh Jain University of Nebraska Medical Center Omaha, Nebraska April 2017 ii iii Role of Endothelin Axis in Pancreatic Tumor Microenvironment (TME) Suprit Gupta, PhD. University of Nebraska Medical Center 2017 Supervisor: Maneesh Jain, PhD. Endothelins (ETs) are a family of three 21 amino-acid vasoactive peptides ET-1, ET-2 and ET-3 that mediate their effects via two G-protein couple receptors ETAR and ETBR which are expressed on various cell types. Apart from their physiological role in vasoconstriction, there is emerging evidence supporting the role of endothelin axis (ET- axis) in cancer. Due to the expression of ET receptors on various cell-types, ET-axis can exert pleotropic effects and contribute to various aspects of cancer pathobiology.
    [Show full text]
  • Leptin in Atherosclerosis: Focus on Macrophages, Endothelial and Smooth Muscle Cells
    International Journal of Molecular Sciences Review Leptin in Atherosclerosis: Focus on Macrophages, Endothelial and Smooth Muscle Cells Priya Raman 1,2,* and Saugat Khanal 1,2 1 Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH 44272, USA; [email protected] 2 School of Biomedical Sciences, Kent State University, Kent, OH 44240, USA * Correspondence: [email protected]; Tel.: +1-(330)-325-6425; Fax: +1-(330)-325-5912 Abstract: Increasing adipose tissue mass in obesity directly correlates with elevated circulating leptin levels. Leptin is an adipokine known to play a role in numerous biological processes including regu- lation of energy homeostasis, inflammation, vascular function and angiogenesis. While physiological concentrations of leptin may exhibit multiple beneficial effects, chronically elevated pathophysio- logical levels or hyperleptinemia, characteristic of obesity and diabetes, is a major risk factor for development of atherosclerosis. Hyperleptinemia results in a state of selective leptin resistance such that while beneficial metabolic effects of leptin are dampened, deleterious vascular effects of leptin are conserved attributing to vascular dysfunction. Leptin exerts potent proatherogenic effects on multiple vascular cell types including macrophages, endothelial cells and smooth muscle cells; these effects are mediated via an interaction of leptin with the long form of leptin receptor, abundantly expressed in atherosclerotic plaques. This review provides a summary of recent in vivo and in vitro studies that highlight a role of leptin in the pathogenesis of atherosclerotic complications associated with obesity and diabetes. Citation: Raman, P.; Khanal, S. Keywords: hyperleptinemia; endothelial cells; vascular smooth muscle cells; macrophages; atherosclerosis Leptin in Atherosclerosis: Focus on Macrophages, Endothelial and Smooth Muscle Cells.
    [Show full text]